Progress and perspective in the treatment of lung cancer

Saved in:
Bibliographic Details
Group Author: Houtte Paul van, 1949-; Klastersky J.; (Jean); Rocmans P., 1937-; Albain K. S.; (Kathy S.)
Published: Springer,
Publisher Address: Berlin New York
Publication Dates: c1999.
Literature type: Book
Language: English
Series: Medical radiology,
Subjects:
Carrier Form: x, 280 p.: ill. (some col.) ; 28 cm.
ISBN: 3540625488 (alk. paper)
Index Number: R734
CLC: R734.205
Call Number: R734.205/P964
Contents: Includes bibliographical references and index.
Ch. 1. Prognostic factors: from clinical parameters to new biological markers-- Ch. 2. Radiological evaluation of intrathoracic extension and resectability of non-small cell lung cancer-- Ch. 3. Positron emission tomography: a new tool in diagnosing staging and treatment monitoring of lung cancer-- Ch. 4. Exclusive surgery for stage III disease: Is it still ethical?-- Ch. 5. Induction chemotherapy with or without radiotherapy followed by surgery in non-small cell lung cancer-- Ch. 6. Adjuvant treatment in non-small cell lung cancer Ch. 7. Induction or concurrent chemotherapy and radiation therapy for locally advanced non-small cell lung cancer-- Ch. 8. Exclusive radiotherapy for NSC lung cancer-- Ch. 9. Three-dimensional conformal radiotherapy in treatment of bronchogenic carcinoma-- Ch. 10. Endoluminal brachytherapy: a curative modality?-- Ch. 11. Integration of radiation therapy and chemotherapy for small cell lung cancer-- Ch. 12. The role of prophylactic cranial irradiation: benefits and late effects-- Ch. 13. Fractionation as a biological dose modifier Ch. 14. Biochemical and biological dose modifiers for irradiation of lung cancers-- Ch. 15. Intraoperative radiotherapy for lung cancer-- Ch. 16. Should all stage IV non-small cell lung cancer be treated palliatively?-- Ch. 17. Intensive therapy of small cell lung cancer: a review of recently published data-- Ch. 18. Best supportive care or chemotherapy for stage IV non-small cell lung cancer-- Ch. 19. Do we have the real tools to evaluate lung radiotoxicity?-- Ch. 20. Treatment indications and clinical target volume Ch. 21. Radiotherapy and the challenge of palliation-- Ch. 22. New drugs in lung cancer-- Ch. 23. Supportive treatment in the management of lung cancer.